0001072588-14-000053.txt : 20140520
0001072588-14-000053.hdr.sgml : 20140520
20140520164855
ACCESSION NUMBER: 0001072588-14-000053
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140519
ITEM INFORMATION: Entry into a Material Definitive Agreement
FILED AS OF DATE: 20140520
DATE AS OF CHANGE: 20140520
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PEPTIDE TECHNOLOGIES, INC.
CENTRAL INDEX KEY: 0001357878
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 980479983
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1130
FILING VALUES:
FORM TYPE: 8-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53230
FILM NUMBER: 14858487
BUSINESS ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: TWO UNION SQUARE, 42ND FLOOR
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: (206) 388-5498
MAIL ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: TWO UNION SQUARE, 42ND FLOOR
CITY: SEATTLE
STATE: WA
ZIP: 98101
FORMER COMPANY:
FORMER CONFORMED NAME: CREENERGY Corp
DATE OF NAME CHANGE: 20100818
FORMER COMPANY:
FORMER CONFORMED NAME: ONLINE ORIGINALS, INC
DATE OF NAME CHANGE: 20060330
8-K
1
pept8kextofagr.txt
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: May 19, 2014
PEPTIDE TECHNOLOGIES, INC.
--------------------------
(Exact name of registrant as specified in its charter)
Nevada 333-133347 98-0479983
(State or other (Commission File Number) (IRS Employer Number)
jurisdiction of
incorporation)
601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
-------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(206) 388-5498
--------------
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS
Item 1.01 Entry into a Material Definitive Agreement
On December 11, 2012, the Company formally engaged BB&T Capital Markets
("BB&TCM") to act as the Company's exclusive financial advisor and agent in
connection with developing strategic alternatives for the Company regarding debt
financings, licensing of intellectual properties developed by the Company,
equity raises, sale of intellectual properties, or other capital markets
transactions that may develop over the course of a 24 month agreement.
On May 19, 2014, the Company renewed/extended the Agreement with BB&T Capital
Markets. The extension runs from May 1, 2014 through May 1, 2016 (24 months).
All other provisions of the Agreement remain unchanged.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
PEPTIDE TECHNOLOGIES, INC.
By: /s/ J. Erik Odeen
-------------------------------
J. Erik Odeen
CFO
Date: May 19, 2014